Cargando…
Effects of house dust mite subcutaneous immunotherapy in real-life. Immunological and clinical biomarkers and economic impact analysis
BACKGROUND: Etiology of allergic rhinitis and asthma is frequently associated with house dust mite sensitization and allergen immunotherapy (AIT) represents the only disease modifying treatment. In a real world setting, clinicians would benefit from biomarkers to monitor or predict response to AIT....
Autores principales: | Caruso, Cristiano, Colantuono, Stefania, Tolusso, Barbara, Di Mario, Clara, Fancello, Giovanni, La Sorda, Marilena, Celi, Giorgio, Caringi, Mario, Volterrani, Anna, Descalzi, Desideria, Gremese, Elisa, Sanguinetti, Maurizio, Gasbarrini, Antonio, Canonica, Giorgio Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10362513/ https://www.ncbi.nlm.nih.gov/pubmed/37484874 http://dx.doi.org/10.1016/j.waojou.2023.100789 |
Ejemplares similares
-
Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial
por: Bożek, Andrzej, et al.
Publicado: (2017) -
Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report
por: Caruso, C., et al.
Publicado: (2020) -
Allergen immunotherapy for house dust mite-induced rhinitis: prescriptive criteria
por: Incorvaia, Cristoforo, et al.
Publicado: (2021) -
Safety of house dust mite subcutaneous immunotherapy in preschool children with respiratory allergic diseases
por: Yang, Yaqi, et al.
Publicado: (2021) -
House Dust Mite Subcutaneous Immunotherapy and Lung Function Trajectory in Children and Adolescents with Asthma
por: Nogami, Kazutaka, et al.
Publicado: (2022)